August 2019 Issue

GO TO FULL ISSUE

Get Enterprise-wide Access

Med Updates

Skyrizi
risankizumab
An interleukin-23 antagonist for moderate to severe plaque psoriasis.

Vyzulta
latanoprostene bunod
A prostaglandin analogue ophthalmic solution to lower intraocular pressure.

Radicava
edaravone
An intravenous treatment for amyotrophic lateral sclerosis (ALS)

More Med Updates